30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Arthur Tzianabos

Track

Insider profile

Currently holds positions in Akouos Inc, Stoke Therapeutics Inc and Q32 Bio Inc

Positions

Position Company Period
Director Akouos Inc None -
Independent Director Stoke Therapeutics Inc Sept. 1, 2018 -
President, Chief Executive Officer, Director Q32 Bio Inc Jan. 1, 2016 -
President, Chief Scientific Officer Millendo Therapeutics Inc Dec. 9, 2014 - March 31, 2016
President, Chief Executive Officer Q32 Bio Inc None -
Chief Scientific Officer Millendo Therapeutics Inc July 30, 2013 - Dec. 9, 2014
Arthur Tzianabos's trades of Stoke Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-12 2026-03-10
PlS Planned sale
90,530 -8.2%
209.17
US$3,221,512 		90,530 -8.2% 209.17 US$3,221,512
2026-03-10 2026-03-10
PrS Proposed sale
36,695
433.14
US$3,069,295 		36,695 433.14 US$3,069,295
2024-08-14 2024-03-25
US Q32 Bio Inc (QTTB)
S Sale
2,864 +48.7%
324.78
US$1,952,934 		2,864 +48.7% 324.78 US$1,952,934
2024-02-15 2024-01-09
US Q32 Bio Inc (QTTB)
PlS Planned sale
13,037 -9.2%
0.57
US$7,445 		13,037 -9.2% 0.57 US$7,445
2023-01-11 2023-01-09
US Q32 Bio Inc (QTTB)
PlS Planned sale
10,616 -8.9%
1.39
US$14,762 		10,616 -8.9% 1.39 US$14,762
2022-01-12 2022-01-05
US Q32 Bio Inc (QTTB)
PlS Planned sale
5,354 -5.9%
3.78
US$20,239 		5,354 -5.9% 3.78 US$20,239
2021-02-23 2021-02-19
PlS Planned sale
10,000 -100.0%
60.67
US$606,652 		10,000 -100.0% 60.67 US$606,652
2020-11-25 2020-11-23
PlS Planned sale
210 -100.0%
47.61
US$9,998 		210 -100.0% 47.61 US$9,998
2020-11-25 2020-11-23
PlS Planned sale
5,294 -96.2%
46.85
US$248,009 		5,294 -96.2% 46.85 US$248,009
2020-11-25 2020-11-23
PlS Planned sale
10,196 -64.9%
45.97
US$468,720 		10,196 -64.9% 45.97 US$468,720
2020-11-25 2020-11-23
PlS Planned sale
4,300 -21.5%
45.08
US$193,838 		4,300 -21.5% 45.08 US$193,838
2020-02-05 2020-02-03
US Q32 Bio Inc (QTTB)
PlS Planned sale
12,500 -13.9%
16.16
US$202,021 		12,500 -13.9% 16.16 US$202,021
2020-01-03 2020-01-02
US Q32 Bio Inc (QTTB)
PlS Planned sale
12,500 -12.2%
20.50
US$256,191 		12,500 -12.2% 20.50 US$256,191
2019-10-02 2019-10-01
US Q32 Bio Inc (QTTB)
PlS Planned sale
100 -0.1%
18.23
US$1,823 		100 -0.1% 18.23 US$1,823
2019-10-02 2019-10-01
US Q32 Bio Inc (QTTB)
PlS Planned sale
12,400 -8.9%
17.39
US$215,645 		12,400 -8.9% 17.39 US$215,645
2019-09-05 2019-09-03
US Q32 Bio Inc (QTTB)
PlS Planned sale
12,500 -8.2%
18.75
US$234,320 		12,500 -8.2% 18.75 US$234,320
2019-07-03 2019-07-01
US Q32 Bio Inc (QTTB)
PlS Planned sale
12,500 -7.0%
18.98
US$237,300 		12,500 -7.0% 18.98 US$237,300
2019-06-05 2019-06-03
US Q32 Bio Inc (QTTB)
PlS Planned sale
12,500 -6.6%
19.86
US$248,262 		12,500 -6.6% 19.86 US$248,262